¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
3/6 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2021-03-05
Á¶È¸¼ö
417


¾È³çÇϼ¼¿ä ö±ÕÀÔ´Ï´Ù. 

À̹ø Åä¿äÀÏ ¼¼¹Ì³ª¿¡¼­ ¹ßÇ¥µå¸± ³í¹®ÀÇ Á¦¸ñÀº "SHP-1 regulates antigen cross-presentation and is exploited by Leishmania to evade immunity"

À̸ç Áö³­ÇØ 12¿ù¿¡ cell report¿¡ ¹ßÇ¥ µÇ¾ú½À´Ï´Ù. 

¼¼Æ÷³» ±â»ý ¼¼±ÕÀÎ Leishmanina  °¡ ºÐºñÇÏ´Â ligand¸¦ ÀνÄÇϴ  Mincle (clec4e) À̶ó´Â C-type lectic receptor¿Í ±× ÇÏÀ§ÀÇ inhibitory ITAM signal¿¡ °ü¿©ÇÏ´Â SHP-1ÀÌ 
±â´ÉÀ» »ó½ÇÇÏ¿´À» ¶§, endosomal pH¸¦ Çâ»ó ½ÃÅ°´Â ¹æ½ÄÀ¸·Î cross-presentationÀÌ Áõ°¡ µÇ´Â °ÍÀ» ¹ÙÅÁÀ¸·Î, 
Mincle/ SHP-1 ÀÌ ±³Â÷Ç׿øÁ¦½Ã¸¦ Á¶ÀýÇÏ¸ç µ¿½Ã¿¡,  Leishmanina °¡ È£½ºÆ®ÀÇ ¸é¿ª½Ã½ºÅÛÀ» ȸÇÇÇÏ´Â ±âÀüÀ¸·Î ÀÌ¿ëÇÔÀ» ¹àÈù ³í¹®ÀÔ´Ï´Ù. 

Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù. 

³í¹® ¸µÅ© : https://www.sciencedirect.com/science/article/pii/S2211124720314571

÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
3/13 ¹ßÇ¥ ³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä. ¿ìÁøÀÔ´Ï´Ù. À̹øÁÖ Á¦°¡ ¹ßÇ¥ÇÒ ³í¹®Àº À̹ø ´Þ Immunity¿¡ °ÔÀçµÈ 'Heparin prevents caspase-11 dependent septic lethality independent of anticoagulant preperties' ÀÔ´Ï´Ù. ÇØ´ç ¿¬±¸ÁøÀº 3³â Àümurine sepsis model¿¡¼­ HMGB1°ú LPSÀÇ interaction¿¡ ÀÇÇÑcaspase 11 dependent pyroptos..
ÀÌÀü±Û
3/6 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ³ª·¡ÀÔ´Ï´Ù. Á¦°¡ À̹øÁÖ ¹ßÇ¥ÇÏ°ÔµÉ ³í¹®Àº 2017³â cell reports¿¡ °ÔÀçµÈ ³í¹®À¸·Î Á¦¸ñÀº "Biophysical attributes of CpG presentation control TLR9 signaling to differentially polarize systemic immune reponses"À̸ç, PEI-PLGA¶ó´Â Micro- Nano particle¿¡ CpG¸¦ ·Îµù..